ID   PTN2_RAT                Reviewed;         416 AA.
AC   P35233;
DT   01-FEB-1994, integrated into UniProtKB/Swiss-Prot.
DT   16-NOV-2011, sequence version 2.
DT   02-OCT-2024, entry version 171.
DE   RecName: Full=Tyrosine-protein phosphatase non-receptor type 2;
DE            EC=3.1.3.48;
DE   AltName: Full=Protein-tyrosine phosphatase PTP-S;
GN   Name=Ptpn2;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 4).
RC   TISSUE=Spleen;
RX   PubMed=1849097; DOI=10.1016/0014-5793(91)80205-h;
RA   Swarup G., Kamatkar S., Radha V., Rema V.;
RT   "Molecular cloning and expression of a protein-tyrosine phosphatase showing
RT   homology with transcription factors Fos and Jun.";
RL   FEBS Lett. 280:65-69(1991).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 4).
RC   TISSUE=Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [3]
RP   DNA-BINDING.
RX   PubMed=8443161; DOI=10.1021/bi00060a010;
RA   Radha V., Kamatkar S., Swarup G.;
RT   "Binding of a protein-tyrosine phosphatase to DNA through its carboxy-
RT   terminal noncatalytic domain.";
RL   Biochemistry 32:2194-2201(1993).
RN   [4]
RP   ALTERNATIVE SPLICING.
RX   PubMed=8534367; DOI=10.1089/dna.1995.14.1007;
RA   Reddy R.S., Swarup G.;
RT   "Alternative splicing generates four different forms of a non-transmembrane
RT   protein tyrosine phosphatase mRNA.";
RL   DNA Cell Biol. 14:1007-1015(1995).
RN   [5]
RP   SUBCELLULAR LOCATION (ISOFORMS 1 AND 2).
RX   PubMed=8900155; DOI=10.1074/jbc.271.43.26755;
RA   Kamatkar S., Radha V., Nambirajan S., Reddy R.S., Swarup G.;
RT   "Two splice variants of a tyrosine phosphatase differ in substrate
RT   specificity, DNA binding, and subcellular location.";
RL   J. Biol. Chem. 271:26755-26761(1996).
CC   -!- FUNCTION: Non-receptor type tyrosine-specific phosphatase that
CC       dephosphorylates receptor protein tyrosine kinases including INSR,
CC       EGFR, CSF1R, PDGFR. Also dephosphorylates non-receptor protein tyrosine
CC       kinases like JAK1, JAK2, JAK3, Src family kinases, STAT1, STAT3 and
CC       STAT6 either in the nucleus or the cytoplasm. Negatively regulates
CC       numerous signaling pathways and biological processes like
CC       hematopoiesis, inflammatory response, cell proliferation and
CC       differentiation, and glucose homeostasis. Plays a multifaceted and
CC       important role in the development of the immune system. Functions in T-
CC       cell receptor signaling through dephosphorylation of FYN and LCK to
CC       control T-cells differentiation and activation. Dephosphorylates CSF1R,
CC       negatively regulating its downstream signaling and macrophage
CC       differentiation. Negatively regulates cytokine (IL2/interleukin-2 and
CC       interferon)-mediated signaling through dephosphorylation of the
CC       cytoplasmic kinases JAK1, JAK3 and their substrate STAT1, that
CC       propagate signaling downstream of the cytokine receptors. Also
CC       regulates the IL6/interleukin-6 and IL4/interleukin-4 cytokine
CC       signaling through dephosphorylation of STAT3 and STAT6 respectively. In
CC       addition to the immune system, it is involved in anchorage-dependent,
CC       negative regulation of EGF-stimulated cell growth. Activated by the
CC       integrin ITGA1/ITGB1, it dephosphorylates EGFR and negatively regulates
CC       EGF signaling. Dephosphorylates PDGFRB and negatively regulates
CC       platelet-derived growth factor receptor-beta signaling pathway and
CC       therefore cell proliferation. Negatively regulates tumor necrosis
CC       factor-mediated signaling downstream via MAPK through SRC
CC       dephosphorylation. May also regulate the hepatocyte growth factor
CC       receptor signaling pathway through dephosphorylation of the hepatocyte
CC       growth factor receptor MET. Also plays an important role in glucose
CC       homeostasis. For instance, negatively regulates the insulin receptor
CC       signaling pathway through the dephosphorylation of INSR and control
CC       gluconeogenesis and liver glucose production through negative
CC       regulation of the IL6 signaling pathways. May also bind DNA (By
CC       similarity). {ECO:0000250|UniProtKB:P17706}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H2O + O-phospho-L-tyrosyl-[protein] = L-tyrosyl-[protein] +
CC         phosphate; Xref=Rhea:RHEA:10684, Rhea:RHEA-COMP:10136, Rhea:RHEA-
CC         COMP:10137, ChEBI:CHEBI:15377, ChEBI:CHEBI:43474, ChEBI:CHEBI:46858,
CC         ChEBI:CHEBI:82620; EC=3.1.3.48; Evidence={ECO:0000255|PROSITE-
CC         ProRule:PRU10044};
CC   -!- SUBUNIT: Interacts with RMDN3. Interacts with TMED9. Interacts with
CC       STX17; dephosphorylates STX17. Interacts with ITGA1 (via cytoplasmic
CC       domain); activates the phosphatase activity towards EGFR. Interacts
CC       with TRAF2; probably involved in tumor necrosis factor-mediated
CC       signaling. Interacts with MET (By similarity). Interacts with FAM220A
CC       and STAT3; interaction with FAM220A promotes interaction of PTPN2 with
CC       transcriptional activator STAT3, leading to dephosphorylation of STAT3
CC       by PTPN2 and negative regulation of STAT3 transcriptional activator
CC       activity (By similarity). {ECO:0000250|UniProtKB:P17706,
CC       ECO:0000250|UniProtKB:Q06180}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm. Endoplasmic reticulum-Golgi
CC       intermediate compartment {ECO:0000250}. Note=Targeted to the
CC       endoplasmic reticulum by its C-terminal hydrophobic region.
CC       {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: [Isoform 1]: Endoplasmic reticulum
CC       {ECO:0000269|PubMed:8900155}. Nucleus membrane
CC       {ECO:0000269|PubMed:8900155}.
CC   -!- SUBCELLULAR LOCATION: [Isoform 2]: Nucleus {ECO:0000250}. Cytoplasm
CC       {ECO:0000250}. Cell membrane {ECO:0000250}. Note=Predominantly
CC       localizes to chromatin. Able to shuttle between the nucleus and the
CC       cytoplasm and to dephosphorylate plasma membrane receptors. Recruited
CC       by activated ITGA1 at the plasma membrane (By similarity).
CC       {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC       Name=1; Synonyms=PTP-S4;
CC         IsoId=P35233-1; Sequence=Displayed;
CC       Name=2; Synonyms=PTP-S2;
CC         IsoId=P35233-2; Sequence=VSP_042002;
CC       Name=3; Synonyms=PTP-S3;
CC         IsoId=P35233-3; Sequence=VSP_042001;
CC       Name=4; Synonyms=PTP-S1;
CC         IsoId=P35233-4; Sequence=VSP_042001, VSP_042002;
CC   -!- TISSUE SPECIFICITY: Does not show tissue- or cell-type specificity
CC       although levels of transcription show variability. Macrophages showed
CC       higher levels of expression than lymphocytes.
CC   -!- PTM: [Isoform 2]: Specifically phosphorylated in a cell cycle-dependent
CC       manner by cyclin-dependent kinases CDK1 and CDK2. Probably activated
CC       through phosphorylation by PKR. {ECO:0000250|UniProtKB:P17706}.
CC   -!- MISCELLANEOUS: [Isoform 3]: Minor. {ECO:0000305}.
CC   -!- MISCELLANEOUS: [Isoform 4]: Minor. {ECO:0000305}.
CC   -!- SIMILARITY: Belongs to the protein-tyrosine phosphatase family. Non-
CC       receptor class 1 subfamily. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; X58828; CAA41633.1; -; mRNA.
DR   EMBL; BC078758; AAH78758.1; -; mRNA.
DR   PIR; S14294; S14294.
DR   RefSeq; NP_446442.1; NM_053990.1. [P35233-4]
DR   AlphaFoldDB; P35233; -.
DR   SMR; P35233; -.
DR   IntAct; P35233; 1.
DR   STRING; 10116.ENSRNOP00000023763; -.
DR   BindingDB; P35233; -.
DR   PhosphoSitePlus; P35233; -.
DR   jPOST; P35233; -.
DR   PaxDb; 10116-ENSRNOP00000063665; -.
DR   GeneID; 117063; -.
DR   KEGG; rno:117063; -.
DR   UCSC; RGD:620710; rat. [P35233-1]
DR   AGR; RGD:620710; -.
DR   CTD; 5771; -.
DR   RGD; 620710; Ptpn2.
DR   VEuPathDB; HostDB:ENSRNOG00000017453; -.
DR   eggNOG; KOG0789; Eukaryota.
DR   InParanoid; P35233; -.
DR   OrthoDB; 2911650at2759; -.
DR   Reactome; R-RNO-6807004; Negative regulation of MET activity.
DR   Reactome; R-RNO-877312; Regulation of IFNG signaling.
DR   Reactome; R-RNO-9833482; PKR-mediated signaling.
DR   PRO; PR:P35233; -.
DR   Proteomes; UP000002494; Chromosome 18.
DR   Bgee; ENSRNOG00000017453; Expressed in thymus and 20 other cell types or tissues.
DR   GO; GO:0005737; C:cytoplasm; IBA:GO_Central.
DR   GO; GO:0005783; C:endoplasmic reticulum; ISS:UniProtKB.
DR   GO; GO:0005793; C:endoplasmic reticulum-Golgi intermediate compartment; ISS:UniProtKB.
DR   GO; GO:0031904; C:endosome lumen; ISO:RGD.
DR   GO; GO:0031965; C:nuclear membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005634; C:nucleus; ISS:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; ISO:RGD.
DR   GO; GO:0003677; F:DNA binding; TAS:RGD.
DR   GO; GO:0005178; F:integrin binding; ISO:RGD.
DR   GO; GO:0004726; F:non-membrane spanning protein tyrosine phosphatase activity; IDA:RGD.
DR   GO; GO:0019901; F:protein kinase binding; ISO:RGD.
DR   GO; GO:0004725; F:protein tyrosine phosphatase activity; ISS:UniProtKB.
DR   GO; GO:0030971; F:receptor tyrosine kinase binding; ISO:RGD.
DR   GO; GO:0097677; F:STAT family protein binding; ISO:RGD.
DR   GO; GO:0019905; F:syntaxin binding; ISO:RGD.
DR   GO; GO:0030183; P:B cell differentiation; ISS:UniProtKB.
DR   GO; GO:0030218; P:erythrocyte differentiation; ISS:UniProtKB.
DR   GO; GO:0042593; P:glucose homeostasis; ISS:UniProtKB.
DR   GO; GO:0038020; P:insulin receptor recycling; ISO:RGD.
DR   GO; GO:0008286; P:insulin receptor signaling pathway; ISS:UniProtKB.
DR   GO; GO:0008285; P:negative regulation of cell population proliferation; ISS:UniProtKB.
DR   GO; GO:0050922; P:negative regulation of chemotaxis; ISS:UniProtKB.
DR   GO; GO:0042059; P:negative regulation of epidermal growth factor receptor signaling pathway; ISS:UniProtKB.
DR   GO; GO:0070373; P:negative regulation of ERK1 and ERK2 cascade; ISS:UniProtKB.
DR   GO; GO:0050728; P:negative regulation of inflammatory response; ISS:UniProtKB.
DR   GO; GO:0046627; P:negative regulation of insulin receptor signaling pathway; ISS:UniProtKB.
DR   GO; GO:1902206; P:negative regulation of interleukin-2-mediated signaling pathway; ISS:UniProtKB.
DR   GO; GO:1902215; P:negative regulation of interleukin-4-mediated signaling pathway; ISS:UniProtKB.
DR   GO; GO:0070104; P:negative regulation of interleukin-6-mediated signaling pathway; ISS:UniProtKB.
DR   GO; GO:0010888; P:negative regulation of lipid storage; ISS:UniProtKB.
DR   GO; GO:1902227; P:negative regulation of macrophage colony-stimulating factor signaling pathway; ISS:UniProtKB.
DR   GO; GO:0045650; P:negative regulation of macrophage differentiation; ISS:UniProtKB.
DR   GO; GO:2000587; P:negative regulation of platelet-derived growth factor receptor-beta signaling pathway; ISS:UniProtKB.
DR   GO; GO:1902233; P:negative regulation of positive thymic T cell selection; ISS:UniProtKB.
DR   GO; GO:0046426; P:negative regulation of receptor signaling pathway via JAK-STAT; IBA:GO_Central.
DR   GO; GO:0050860; P:negative regulation of T cell receptor signaling pathway; ISS:UniProtKB.
DR   GO; GO:0000122; P:negative regulation of transcription by RNA polymerase II; ISO:RGD.
DR   GO; GO:0010804; P:negative regulation of tumor necrosis factor-mediated signaling pathway; ISS:UniProtKB.
DR   GO; GO:0060339; P:negative regulation of type I interferon-mediated signaling pathway; ISS:UniProtKB.
DR   GO; GO:0060336; P:negative regulation of type II interferon-mediated signaling pathway; ISS:UniProtKB.
DR   GO; GO:0042532; P:negative regulation of tyrosine phosphorylation of STAT protein; ISS:UniProtKB.
DR   GO; GO:0035335; P:peptidyl-tyrosine dephosphorylation; ISS:UniProtKB.
DR   GO; GO:1902237; P:positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway; ISO:RGD.
DR   GO; GO:0045722; P:positive regulation of gluconeogenesis; ISS:UniProtKB.
DR   GO; GO:1903899; P:positive regulation of PERK-mediated unfolded protein response; ISO:RGD.
DR   GO; GO:1902202; P:regulation of hepatocyte growth factor receptor signaling pathway; ISS:UniProtKB.
DR   GO; GO:0030217; P:T cell differentiation; ISS:UniProtKB.
DR   Gene3D; 3.90.190.10; Protein tyrosine phosphatase superfamily; 1.
DR   InterPro; IPR051985; NR_tyrosine_phosphatase.
DR   InterPro; IPR029021; Prot-tyrosine_phosphatase-like.
DR   InterPro; IPR000242; PTP_cat.
DR   InterPro; IPR012265; Ptpn1/Ptpn2.
DR   InterPro; IPR016130; Tyr_Pase_AS.
DR   InterPro; IPR003595; Tyr_Pase_cat.
DR   InterPro; IPR000387; Tyr_Pase_dom.
DR   PANTHER; PTHR46047:SF1; TYROSINE-PROTEIN PHOSPHATASE NON-RECEPTOR TYPE 2; 1.
DR   PANTHER; PTHR46047; TYROSINE-PROTEIN PHOSPHATASE NON-RECEPTOR TYPE 61F; 1.
DR   Pfam; PF00102; Y_phosphatase; 1.
DR   PIRSF; PIRSF000926; Tyr-Ptase_nr1; 1.
DR   PRINTS; PR00700; PRTYPHPHTASE.
DR   SMART; SM00194; PTPc; 1.
DR   SMART; SM00404; PTPc_motif; 1.
DR   SUPFAM; SSF52799; (Phosphotyrosine protein) phosphatases II; 1.
DR   PROSITE; PS00383; TYR_PHOSPHATASE_1; 1.
DR   PROSITE; PS50056; TYR_PHOSPHATASE_2; 1.
DR   PROSITE; PS50055; TYR_PHOSPHATASE_PTP; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Cell membrane; Cytoplasm; Endoplasmic reticulum;
KW   Hydrolase; Membrane; Nucleus; Phosphoprotein; Protein phosphatase;
KW   Reference proteome; S-nitrosylation.
FT   CHAIN           1..416
FT                   /note="Tyrosine-protein phosphatase non-receptor type 2"
FT                   /id="PRO_0000094754"
FT   DOMAIN          5..275
FT                   /note="Tyrosine-protein phosphatase"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00160"
FT   REGION          341..410
FT                   /note="Endoplasmic reticulum location"
FT                   /evidence="ECO:0000250"
FT   REGION          371..410
FT                   /note="May mediate interaction with STX17"
FT                   /evidence="ECO:0000250"
FT   ACT_SITE        216
FT                   /note="Phosphocysteine intermediate"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00160,
FT                   ECO:0000255|PROSITE-ProRule:PRU10044"
FT   BINDING         182
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000250"
FT   BINDING         216..222
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000250"
FT   BINDING         260
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         22
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:P18031"
FT   MOD_RES         52
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P18031"
FT   MOD_RES         68
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:P18031"
FT   MOD_RES         216
FT                   /note="S-nitrosocysteine"
FT                   /evidence="ECO:0000250|UniProtKB:P18031"
FT   MOD_RES         293
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P17706"
FT   MOD_RES         298
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P17706"
FT   MOD_RES         304
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P17706"
FT   MOD_RES         320
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q06180"
FT   MOD_RES         339
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P18031"
FT   VAR_SEQ         287..305
FT                   /note="Missing (in isoform 3 and isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:15489334,
FT                   ECO:0000303|PubMed:1849097"
FT                   /id="VSP_042001"
FT   VAR_SEQ         377..410
FT                   /note="Missing (in isoform 2 and isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:15489334,
FT                   ECO:0000303|PubMed:1849097"
FT                   /id="VSP_042002"
FT   MOD_RES         P35233-2:304
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P17706"
SQ   SEQUENCE   416 AA;  48446 MW;  E8FB1E670FFC5308 CRC64;
     MSATIEREFE ELDAQCRWQP LYLEIRNESH DYPHRVAKFP ENRNRNRYRD VSPYDHSRVK
     LQSAENDYIN ASLVDIEEAQ RSYILTQGPL PNTCCHFWLM VWQQKTRAVV MLNRTVEKES
     VKCAQYWPTD DREMVFKETG FSVKLLSEDV KSYYTVHLLQ LENINSGETR TISHFHYTTW
     PDFGVPESPA SFLNFLFKVR ESGSLNPDHG PAVIHCSAGI GRSGTFSLVD TCLVLMEKGE
     DVNVKQILLS MRKYRMGLIQ TPDQLRFSYM AIIEGAKYTK GDSNIQKRWK ELSKEDLSPV
     CRHSQNRTMT EKYNGKRIGS EDEKLTGLSS KVPDTVEESS ESILRKRIRE DRKATTAQKV
     QQMRQRLNET ERKRKRWLYW QPILTKMGFV SVILVGALVG WTLLFQLNVL PRLTDT
//
